PHIA Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €24.40 |
| 52 Week High | €30.60 |
| 52 Week Low | €17.41 |
| Beta | 0.79 |
| 11 Month Change | -16.44% |
| 3 Month Change | -6.87% |
| 1 Year Change | 34.22% |
| 33 Year Change | -23.37% |
| 5 Year Change | -34.40% |
| Change since IPO | -49.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHIA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.8% | -3.7% | -0.5% |
| 1Y | 34.2% | -4.2% | 8.3% |
Return vs Industry: PHIA exceeded the German Medical Equipment industry which returned -4.2% over the past year.
Return vs Market: PHIA exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| PHIA volatility | |
|---|---|
| PHIA Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHIA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PHIA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 68,701 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA fundamental statistics | |
|---|---|
| Market cap | €22.94b |
| Earnings (TTM) | -€469.00m |
| Revenue (TTM) | €18.04b |
1.3x
P/S Ratio-48.9x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA income statement (TTM) | |
|---|---|
| Revenue | €18.04b |
| Cost of Revenue | €10.43b |
| Gross Profit | €7.61b |
| Other Expenses | €8.08b |
| Earnings | -€469.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 42.18% |
| Net Profit Margin | -2.60% |
| Debt/Equity Ratio | 69.4% |
How did PHIA perform over the long term?
See historical performance and comparison